BFM
ANAB icon

Boothbay Fund Management’s AnaptysBio ANAB Stock Holding History

Boothbay Fund Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-60,600
Closed -$1.86M – 1945
2025
Q3 		$1.86M Buy
+60,600
New +$1.39M 0.03% 597
2025
Q1 		– Sell
-89,700
Closed -$1.19M – 1388
2024
Q4 		$1.19M Sell
89,700
-28,800
-24% -$698K 0.03% 591
2024
Q3 		$3.97M Buy
+118,500
New +$4.05M 0.09% 315
2020
Q1 		– Sell
-269
Closed -$437K – 838
2019
Q4 		$437K Sell
269
-385
-59% -$9.11K 0.04% 515
2019
Q3 		$2.29M Buy
654
+270
+70% +$12.8K 0.21% 116
2019
Q2 		$2.17M Buy
+384
New +$27.6K 0.2% 134
2018
Q2 		– Sell
-209
Closed -$2.17M – 736
2018
Q1 		$2.17M Buy
+209
New +$23.6K 0.26% 90

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boothbay Fund Management's ANAB Position: Q4 2025 in Review

Boothbay Fund Management sold out of AnaptysBio (ANAB) in Q4 2025, closing a stake of 27,402 shares — an estimated $839K sold.

Boothbay Fund Management first reported a position in ANAB in Q1 2019 and held it in 6 quarters. The position peaked at $1.17M in Q1 2019. 179 funds tracked by Wall St. Rank hold ANAB as of Q4 2025.

  • Boothbay Fund Management reported no remaining AnaptysBio position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 27,402 AnaptysBio shares in Q4 2025, an estimated $839K.
  • Boothbay Fund Management first reported a position in AnaptysBio in Q1 2019 and held it in 6 quarters.
  • Boothbay Fund Management's AnaptysBio position peaked at $1.17M in Q1 2019.
  • 179 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.